Latest News

Mitotic rate not tied to SLN biopsy results in thin melanomas


Key clinical point: The results support the latest guidelines, which exclude mitotic rate in the criteria for upstaging thin melanomas.

Major finding: There was no association between mitotic rate and positive sentinel lymph node biopsy results.

Data source: A retrospective analysis of 990 patient records in Alberta, Canada.

Disclosures: Dr. Wat and Dr. Botto reported no relevant financial disclosures.


AT PDA 2017


FRANCISCO – Mitotic rate was not found to be a good indicator for the outcome of sentinel lymph node (SLN) biopsy in thin tumors, in an analysis of melanoma cases.

   Comments ()

Recommended for You

News & Commentary

Quizzes from MD-IQ

Research Summaries from ClinicalEdge

Next Article: